UK review on gender medicine ‘largely ignored’ in the US, finds journalist

The newly released Cass Review on transgender care for young people has been pivotal in the UK, where the prescription of puberty “blocking” drugs outside research protocols has now ceased. But in the United States, where the treatment-intensive, “gender-affirming” model of care is the norm, the impact of Cass’s four-year investigation and final report has been largely ignored, finds journalist Jennifer Block in The BMJ today. The review concluded that the evidence on use of puberty blockers and hormones for children and teens experiencing gender-related distress is wholly inadequate and Read More